Table 2.
Unadjusted outcomes in critically ill patients with hypertension treated with or without ACEI/ARB.
| Variables | Total (n = 15,352) | ARB/ACEI (n = 5,193) | No-use of ACEI/ARB (n = 10,159) | P-value |
|---|---|---|---|---|
| Hospital mortality [n (%)] | 1,492 (9.7) | 205 (3.9) | 1,287 (12.7) | <0.001 |
| Day mortality [n (%)] | 1,425 (9.3) | 189 (3.6) | 1,236 (12.2) | <0.001 |
| ICU mortality [n (%)] | 914 (6.0) | 91 (1.8) | 823 (8.1) | <0.001 |
| ICU LOS (days) | 1.87 (1.02–3.61) | 1.92 (1.06–3.73) | 1.85 (0.99–3.55) | 0.001 |
| Hospital LOS (days) | 6.25 (3.58–10.96) | 6.58 (3.88–10.96) | 6.04 (3.29–11) | <0.001 |
| SOFA score | 3 (2–6) | 3 (1–5) | 4 (2–6) | <0.001 |